Osteo Arthritis of the Knee
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program1
Sodium hyaluronate solution - 3.36%Phase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2026
2027
IBSA Institut BiochimiqueSodium hyaluronate solution - 3.36%
Clinical Trials (1)
Total enrollment: 704 patients across 1 trials
A Controlled Study to Evaluate Efficacy and Safety of a Single Intra-Articular Injection of HL-01 in the Treatment of Pain in Symptomatic Knee Osteoarthritis
Start: Sep 2026Est. completion: Jun 2027704 patients
Phase 3Not Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.